Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 23 studies | 46% ± 22% | |
| pericyte | 11 studies | 45% ± 14% | |
| connective tissue cell | 9 studies | 48% ± 20% | |
| smooth muscle cell | 8 studies | 25% ± 10% | |
| myofibroblast cell | 6 studies | 36% ± 24% | |
| podocyte | 4 studies | 85% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 1611.97 | 240 / 245 | 95% | 5.65 | 475 / 502 |
| stomach | 100% | 800.69 | 358 / 359 | 81% | 3.44 | 231 / 286 |
| intestine | 100% | 1543.16 | 964 / 966 | 74% | 2.55 | 389 / 527 |
| lung | 100% | 5667.55 | 578 / 578 | 56% | 2.33 | 645 / 1155 |
| esophagus | 96% | 1213.07 | 1394 / 1445 | 55% | 1.54 | 101 / 183 |
| ovary | 100% | 3377.42 | 180 / 180 | 51% | 2.53 | 220 / 430 |
| bladder | 100% | 2208.43 | 21 / 21 | 51% | 1.48 | 256 / 504 |
| kidney | 100% | 2660.92 | 89 / 89 | 47% | 1.58 | 420 / 901 |
| spleen | 100% | 3729.69 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 87% | 988.30 | 753 / 861 | 0% | 0 | 0 / 0 |
| uterus | 72% | 453.00 | 123 / 170 | 13% | 0.58 | 60 / 459 |
| pancreas | 5% | 16.57 | 18 / 328 | 78% | 2.44 | 139 / 178 |
| adrenal gland | 59% | 227.72 | 151 / 258 | 17% | 0.42 | 38 / 230 |
| adipose | 53% | 412.78 | 633 / 1204 | 0% | 0 | 0 / 0 |
| liver | 15% | 48.50 | 35 / 226 | 10% | 0.19 | 42 / 406 |
| blood vessel | 23% | 183.56 | 305 / 1335 | 0% | 0 | 0 / 0 |
| skin | 14% | 80.74 | 245 / 1809 | 2% | 0.60 | 9 / 472 |
| thymus | 2% | 6.45 | 11 / 653 | 1% | 0.01 | 5 / 605 |
| breast | 1% | 5.30 | 4 / 459 | 0% | 0.04 | 2 / 1118 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001657 | Biological process | ureteric bud development |
| GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
| GO_0048286 | Biological process | lung alveolus development |
| GO_0072162 | Biological process | metanephric mesenchymal cell differentiation |
| GO_0048732 | Biological process | gland development |
| GO_0032502 | Biological process | developmental process |
| GO_0030855 | Biological process | epithelial cell differentiation |
| GO_0060435 | Biological process | bronchiole development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0001822 | Biological process | kidney development |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0060539 | Biological process | diaphragm development |
| GO_0060426 | Biological process | lung vasculature development |
| GO_0048536 | Biological process | spleen development |
| GO_0060008 | Biological process | Sertoli cell differentiation |
| GO_0014707 | Biological process | branchiomeric skeletal muscle development |
| GO_0072277 | Biological process | metanephric glomerular capillary formation |
| GO_0001944 | Biological process | vasculature development |
| GO_0060541 | Biological process | respiratory system development |
| GO_0060021 | Biological process | roof of mouth development |
| GO_0060425 | Biological process | lung morphogenesis |
| GO_0001763 | Biological process | morphogenesis of a branching structure |
| GO_0048557 | Biological process | embryonic digestive tract morphogenesis |
| GO_0060766 | Biological process | negative regulation of androgen receptor signaling pathway |
| GO_0032835 | Biological process | glomerulus development |
| GO_0048608 | Biological process | reproductive structure development |
| GO_0007530 | Biological process | sex determination |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0043425 | Molecular function | bHLH transcription factor binding |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0050681 | Molecular function | nuclear androgen receptor binding |
| GO_0070888 | Molecular function | E-box binding |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0042826 | Molecular function | histone deacetylase binding |
| Gene name | TCF21 |
| Protein name | Transcription factor 21 (TCF-21) (Capsulin) (Class A basic helix-loop-helix protein 23) (bHLHa23) (Epicardin) (Podocyte-expressed 1) (Pod-1) |
| Synonyms | POD1 BHLHA23 |
| Description | FUNCTION: Involved in epithelial-mesenchymal interactions in kidney and lung morphogenesis that include epithelial differentiation and branching morphogenesis. May play a role in the specification or differentiation of one or more subsets of epicardial cell types. |
| Accessions | ENST00000237316.3 O43680 ENST00000367882.5 |
